<DOC>
	<DOC>NCT00641719</DOC>
	<brief_summary>The purpose of the study is to investigate safety and efficacy of duloxetine for patients with painful diabetic neuropathy at long-term use.</brief_summary>
	<brief_title>A Long-term Study for the Treatment of Painful Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Outpatients who have completed the 13week treatment in the preceding study (Protocol No. 0715N0831: NCT00552175). Patients who desire to receive continued treatment with LY248686 from the preceding study. Patients with latest glycosylated hemoglobin (HbA1c) â‰¤9.0% before Visit 7. Patients who can provide written consent in person. Patients who concurrently have serious cardiovascular, hepatic, renal, respiratory, or blood disease, or symptomatic peripheral vascular disease, and thus are considered inappropriate to be included in the study. Pregnant patients or women who desire to become pregnant during the study period, and breast feeding patients. Other patients judged by the investigator/subinvestigator to be inappropriate as a subject in this study.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>